Cargando…
Rationale for Considering Oral Idasanutlin as a Therapeutic Option for COVID-19 Patients
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Frontiers Media S.A.
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7403220/ https://www.ncbi.nlm.nih.gov/pubmed/32848765 http://dx.doi.org/10.3389/fphar.2020.01156 |
| _version_ | 1783566909001695232 |
|---|---|
| author | Zauli, Giorgio Tisato, Veronica Secchiero, Paola |
| author_facet | Zauli, Giorgio Tisato, Veronica Secchiero, Paola |
| author_sort | Zauli, Giorgio |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-7403220 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2020 |
| publisher | Frontiers Media S.A. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-74032202020-08-25 Rationale for Considering Oral Idasanutlin as a Therapeutic Option for COVID-19 Patients Zauli, Giorgio Tisato, Veronica Secchiero, Paola Front Pharmacol Pharmacology Frontiers Media S.A. 2020-07-29 /pmc/articles/PMC7403220/ /pubmed/32848765 http://dx.doi.org/10.3389/fphar.2020.01156 Text en Copyright © 2020 Zauli, Tisato and Secchiero http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
| spellingShingle | Pharmacology Zauli, Giorgio Tisato, Veronica Secchiero, Paola Rationale for Considering Oral Idasanutlin as a Therapeutic Option for COVID-19 Patients |
| title | Rationale for Considering Oral Idasanutlin as a Therapeutic Option for COVID-19 Patients |
| title_full | Rationale for Considering Oral Idasanutlin as a Therapeutic Option for COVID-19 Patients |
| title_fullStr | Rationale for Considering Oral Idasanutlin as a Therapeutic Option for COVID-19 Patients |
| title_full_unstemmed | Rationale for Considering Oral Idasanutlin as a Therapeutic Option for COVID-19 Patients |
| title_short | Rationale for Considering Oral Idasanutlin as a Therapeutic Option for COVID-19 Patients |
| title_sort | rationale for considering oral idasanutlin as a therapeutic option for covid-19 patients |
| topic | Pharmacology |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7403220/ https://www.ncbi.nlm.nih.gov/pubmed/32848765 http://dx.doi.org/10.3389/fphar.2020.01156 |
| work_keys_str_mv | AT zauligiorgio rationaleforconsideringoralidasanutlinasatherapeuticoptionforcovid19patients AT tisatoveronica rationaleforconsideringoralidasanutlinasatherapeuticoptionforcovid19patients AT secchieropaola rationaleforconsideringoralidasanutlinasatherapeuticoptionforcovid19patients |